跳至主要内容
临床试验/NCT07607431
NCT07607431进行中(未招募)不适用

Addressing the Forgotten Sex in Lymphedema Research: Risk Factors, Incidence, and Progression of Lymphedema Among Men With Prostate Cancer. The AWARE Cohort

Rigshospitalet, Denmark3 个研究点 分布在 1 个国家目标入组 214 人开始时间: 2024年2月2日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
214
试验地点
3

研究概览

简要总结

The goal of this observational study is to examine the development and impact of lymphedema in men treated for prostate cancer. Lymphedema is swelling caused by damage to the lymphatic system and may develop after surgery with lymph node removal or after radiotherapy.

The main questions it aims to answer are:

How many men develop lower limb lymphedema after prostate cancer treatment? Which men are at highest risk of developing lymphedema? How does lymphedema affect quality of life?

Participants will attend follow-up visits every three months for 18 months at one of three Danish hospital sites: Rigshospitalet, Herlev-Gentofte Hospital, or Zealand University Hospital. At each visit, participants will undergo examinations for signs of lymphedema and complete questionnaires about symptoms, quality of life, and daily functioning. Participants who develop signs of lymphedema during the study will be advised to seek assessment and treatment from the hospital's lymphedema therapist.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age ≥18 years
  • Men diagnosed with any stage prostate cancer
  • Planned prostatectomy with lymph node removal or radiotherapy
  • Able to understand Danish

排除标准

  • History of lymph node dissection/radiotherapy at the level of the pelvic or groin

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Bolette Rafn

Associate Professor

Rigshospitalet, Denmark

研究点 (3)

Loading locations...

相似试验